Malignant hyperthermia (MH)
LABOKLIN Service ID: 8062
Maligant hyperthermia (MH) is an inherited disorder of skeletal muscle characterized by hypercarbia, rhabdomyolysis, generalized skeletal muscle contracture, cardiac dysrhythmia, and renal failure, that develops on exposure to succinylcholine or volatile anesthetic agents. Specific interventions, including use of the calcium release channel antagonist dantrolene, are efficacious in reversing signs of the canine syndrome.
| Method | TaqMan SNP assay |
| Heredity | autosomal dominant |
| Duration | 3 - 5 working days after arrival of the sample in the lab |